Gastroesophageal Reflux Disease (GERD) Before and After Gastric Bypass
The Impact of Gastric Bypass on Gastroesophageal Reflux Disease in Patients With Morbid Obesity: a Prospective Study Based on Montreal Consensus
1 other identifier
observational
53
1 country
1
Brief Summary
The hypothesis of this study was that gastric bypass (GBP) ameliorates gastroesophageal reflux disease (GERD) in morbidly obese patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2007
CompletedFirst Submitted
Initial submission to the registry
August 2, 2009
CompletedFirst Posted
Study publicly available on registry
August 4, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedResults Posted
Study results publicly available
April 4, 2014
CompletedApril 1, 2025
March 1, 2025
5.8 years
August 2, 2009
December 4, 2013
March 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Number of Participants Presenting Reflux Symptoms
Prevalence of typical reflux syndrome according to the Montreal Consensus. This Consensus institutes that GERD can be outlined when troublesome symptoms and/or complications induced by reflux of the gastric content back to the esophagus are present. In order to assess such troublesome symptoms a validated questionnaire translated into Portuguese language was used.
Before GBP, 6 months after GBP and 39 months after GBP
Number of Participants With Esophageal Injury
Syndromes with esophageal injury were represented exclusively by the presence of reflux esophagitis
Before GBP, 6 months after GBP and 39 months after GBP
Number of Participants With Gastroesophageal Reflux Disease (GERD)
Prevalence of GERD in patients characterized according to troublesome symptomatic syndromes assessed through a validated questionnaire based on the Montreal Consensus.
Before GBP, 6 months after GBP and 39 months after GBP
Total Esophageal Acid Exposure at 24h pH Monitoring
Esophageal acid exposure was measured through 24h pH monitoring. During the entire period, esophageal pH was measured and recorded as the percent of time pH was below 4.
Before GBP, 6 months after GBP and 39 months after GBP
Esophageal Acid Exposure at 24h pH Monitoring in Upright Position
Esophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in upright position
Before GBP, 6 months after GBP and 39 months after GBP
Esophageal Acid Exposure at 24h pH Monitoring in Supine Position
Esophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in supine position
Before GBP, 6 months after GBP and 39 months after GBP
Number of Participants With Increased Acid Exposure
Increased Acid Exposure occurs when esophageal pH is \<4 for a period longer than 4% of the total test time on a 24h pH monitoring.
Before GBP, 6 months after GBP and 39 months after GBP
Study Arms (1)
Patients assessed for GERD
Patients who had an open gastric bypass were assessed for GERD before and after surgery following the Montreal Consensus through a validated questionnaire in Portuguese language
Interventions
Open Silastic® ring Roux-en Y gastric bypass was performed through an upper midline incision. A gastric pouch was created by dividing the stomach with a 10-cm stapler from the lesser curvature (7 cm vertically from the cardia) to 1 cm to the left of the Hiss angle. The estimated volume of the gastric pouch was 20 to 30 ml that was banded with a 6.5 cm long Silastic® ring. A gastrojejunal anastomosis was performed with two-layers hand sewn absorbable suture over a 1.2 cm bougie distal to the ring, keeping an alimentary limb with 100 cm in length, and a biliopancreatic limb ranging 60 and 80 cm.
Eligibility Criteria
Primary care clinic patients
You may qualify if:
- Morbid obesity
- Acceptance to undergo open gastric bypass
You may not qualify if:
- Prior gastroesophageal surgery
- Achalasia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clínica Gastrobese
Passo Fundo, Rio Grande do Sul, 99010112, Brazil
Related Publications (1)
Madalosso CA, Gurski RR, Callegari-Jacques SM, Navarini D, Thiesen V, Fornari F. The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: a prospective study based on the Montreal Consensus. Ann Surg. 2010 Feb;251(2):244-8. doi: 10.1097/SLA.0b013e3181bdff20.
PMID: 20010088DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Carlos AS Madalosso, Director of Department of Metabolic and Bariatric Surgery
- Organization
- Clinica Gastrobese
Study Officials
- PRINCIPAL INVESTIGATOR
Carlos AS Madalosso, PhD
Clinica Gastrobese
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Department of Metabolic and Bariatric Surgery
Study Record Dates
First Submitted
August 2, 2009
First Posted
August 4, 2009
Study Start
March 1, 2007
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
April 1, 2025
Results First Posted
April 4, 2014
Record last verified: 2025-03